134 related articles for article (PubMed ID: 2107480)
21. Ten-year outcome of patients with advanced epithelial ovarian carcinoma treated with cisplatin-based multimodality therapy.
Hoskins PJ; O'Reilly SE; Swenerton KD; Spinelli JJ; Fairey RN; Benedet JL
J Clin Oncol; 1992 Oct; 10(10):1561-8. PubMed ID: 1403035
[TBL] [Abstract][Full Text] [Related]
22. Randomized trial comparing two combination chemotherapy regimens (CHAP-5 v CP) in advanced ovarian carcinoma.
Neijt JP; ten Bokkel Huinink WW; van der Burg ME; van Oosterom AT; Willemse PH; Heintz AP; van Lent M; Trimbos JB; Bouma J; Vermorken JB
J Clin Oncol; 1987 Aug; 5(8):1157-68. PubMed ID: 3114434
[TBL] [Abstract][Full Text] [Related]
23. High-intensity intravenous cyclophosphamide and cisplatin, interim surgical debulking, and intraperitoneal cisplatin in advanced ovarian carcinoma: a pilot trial with ten-year follow-up.
Shapiro F; Schneider J; Markman M; Reichman BS; Venkatraman E; Barakat R; Almadrones L; Spriggs D
Gynecol Oncol; 1997 Oct; 67(1):39-45. PubMed ID: 9345354
[TBL] [Abstract][Full Text] [Related]
24. Five-year survival for cisplatin-based chemotherapy versus single-agent melphalan in patients with advanced ovarian cancer and optimal debulking surgery.
River MS; Fanning J; Sprance HE
J Surg Oncol; 1991 Sep; 48(1):39-44. PubMed ID: 1890837
[TBL] [Abstract][Full Text] [Related]
25. Cisplatin (P) versus cyclophosphamide, adriamycin and cisplatin (CAP) for stage III-IV epithelial ovarian carcinoma: a prospective randomized trial.
Tomirotti M; Perrone S; Giè P; Canaletti R; Carpi A; Biasoli R; Lombardi F; Giovanninetti A; Mensi F; Villa S
Tumori; 1988 Oct; 74(5):573-7. PubMed ID: 3217992
[TBL] [Abstract][Full Text] [Related]
26. Randomised comparison of cisplatin with cyclophosphamide/cisplatin and with cyclophosphamide/doxorubicin/cisplatin in advanced ovarian cancer. Gruppo Interegionale Cooperativo Oncologico Ginecologia.
Lancet; 1987 Aug; 2(8555):353-9. PubMed ID: 2886821
[TBL] [Abstract][Full Text] [Related]
27. Modulation and intensification of a cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin ovarian cancer regimen.
Bruckner HW; Cohen CJ; Feuer E; Holland JF
Obstet Gynecol; 1989 Mar; 73(3 Pt 1):349-56. PubMed ID: 2492648
[TBL] [Abstract][Full Text] [Related]
28. Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience.
Omura GA; Brady MF; Homesley HD; Yordan E; Major FJ; Buchsbaum HJ; Park RC
J Clin Oncol; 1991 Jul; 9(7):1138-50. PubMed ID: 1904477
[TBL] [Abstract][Full Text] [Related]
29. [Effect of 2 different forms of chemotherapy on remission in patients with advanced ovarian cancer].
Krommer K; Keller G; Csaba I; Garadnay B; Göcze P
Zentralbl Gynakol; 1990; 112(17):1105-10. PubMed ID: 2264421
[TBL] [Abstract][Full Text] [Related]
30. Tumor debulking followed by immediate combination chemotherapy in advanced ovarian carcinoma. Phase II.
Vardi JR; Tadros GH; Zamurovic D; Rafla SD
Acta Obstet Gynecol Scand; 1992 Jul; 71(5):361-7. PubMed ID: 1326212
[TBL] [Abstract][Full Text] [Related]
31. Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study.
Omura GA; Bundy BN; Berek JS; Curry S; Delgado G; Mortel R
J Clin Oncol; 1989 Apr; 7(4):457-65. PubMed ID: 2926470
[TBL] [Abstract][Full Text] [Related]
32. A randomized trial of cyclophosphamide, doxorubicin, and cisplatin with or without bacillus Calmette-Guerin in patients with suboptimal stage III and IV ovarian cancer: a Gynecologic Oncology Group study.
Creasman WT; Omura GA; Brady MF; Yordan E; DiSaia PJ; Beecham J
Gynecol Oncol; 1990 Dec; 39(3):239-43. PubMed ID: 2258063
[TBL] [Abstract][Full Text] [Related]
33. Long-term survival after chemotherapy with cisplatinum, adriamycin and cyclophosphamide for carcinoma of the ovary.
Davidson NG; Khanna S; Kirwan PH; Naftalin NJ; Roy UK; Chui D; Mitchell S
Clin Oncol (R Coll Radiol); 1990 Jul; 2(4):206-9. PubMed ID: 2261416
[TBL] [Abstract][Full Text] [Related]
34. Sequential cisplatin-doxorubicin, early debulking surgery and intraperitoneal chemotherapy in advanced ovarian cancer. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD).
de Gramont A; Demuynck B; Varette C; Louvet C; Pigne A; Marpeau L; Lagadec B; Cady J; Couturier JY; Delfau S
Eur J Cancer; 1992; 28(1):53-8. PubMed ID: 1567692
[TBL] [Abstract][Full Text] [Related]
35. Hexamethylmelamine, adriamycin, and cyclophosphamide (HAC) versus cis-dichlorodiamineplatinum, adriamycin, and cyclophosphamide (PAC) in advanced ovarian cancer: a randomized clinical trial.
Sessa C; Bolis G; Colombo N; D'Incalci M; Mermillod B; Valente I; Mangioni C
Cancer Chemother Pharmacol; 1985; 14(3):222-8. PubMed ID: 3922639
[TBL] [Abstract][Full Text] [Related]
36. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR
Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
[TBL] [Abstract][Full Text] [Related]
37. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
[TBL] [Abstract][Full Text] [Related]
38. Whole abdomen radiation therapy after a short chemotherapy course and second-look laparotomy in advanced ovarian cancer.
Franchin G; Tumolo S; Scarabelli C; De Paoli A; Boz G; Crivellari D; Arcicasa M; Bortolus R; Gobitti C; Minatel E
Gynecol Oncol; 1991 Jun; 41(3):206-11. PubMed ID: 1869096
[TBL] [Abstract][Full Text] [Related]
39. Six-drug chemotherapy (hexamethylmelamine, doxorubicin, cisplatin, cyclophosphamide, methotrexate, and 5-FU; CHAMP-5) for ovarian carcinoma: alternating sequences of combination regimens.
Pasmantier MW; Coleman M; Silver RT; Ballard WP
Cancer Treat Rep; 1985 Jun; 69(6):689-93. PubMed ID: 3926310
[TBL] [Abstract][Full Text] [Related]
40. Hexamethylmelamine, cyclophosphamide, adriamycin, cis-platinum chemotherapy as initial and second-line treatment of advanced ovarian carcinoma.
Richman CM; Podczaski E; Weiser PA; Herbst AL
Oncology; 1986; 43(1):12-7. PubMed ID: 3079898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
